Phase 2 Study of S-1 as 2nd Line Therapy in Metastatic Pancreatic Cancer

NCT00652054 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
39
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Taiho Oncology, Inc.

Collaborators